XTbio, Inc., is a privately held biotechnology company founded by a professor for the University of North Carolina at Chapel Hill, in partnership with,a life science entrepreneur and managing partner of SilverSky Life Sciences, based in Düsseldorf, Germany. With initial funding through government loans and research grants, in 2013, GSK made the firm a drug discovery award based on work to uncover potential targets for therapies that could have major implications for menâs health and cancer treatment. In 2016, KXTbio received additional funding from a family office with international ties to the pharmaceutical industry. Specializing in protein research, GTPases, phospholipase C, and high throughput assays, KXTbio, Inc. is focused on creating 95% pure and active proteins for academic and institutional research institution
